Posted by Michael Wonder on 19 Jul 2020
US purchases world stocks of remdesivir: why the rest of the world should be glad to be at the back of the queue
18 July 2020 - The remdesivir story may actually be good news for the rest of the world.
On 30 June, the Guardian ran an article with the headline “US secures world stock of key COVID-19 drug remdesivir,” lamenting the monopolisation for “the next three months of one of the two drugs proven to work against COVID-19, leaving none for the UK, Europe, or most of the rest of the world.”
This “me first” attitude should surprise nobody familiar with the current US administration’s attitude towards anything involving international collaboration—such as its stance on climate change, the World Health Organization, trade, and immigration.
